Phase 2 Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravenous USB002 to Treat Patients With Respiratory Distress Due to COVID-19 Infection
This trial will study the use of USB002 given as an intravenous infusion in patients with respiratory distress due to infection with COVID-19.